HOME >> MEDICINE >> NEWS
Drug/intervention combinations offer benefit in severe CVD

While millions of Americans suffer from severe cardiac dysfunction, only about 3,000 heart transplants are possible each year. In the meantime, doctors are trying to identify new combinations of medicines and interventions that will increase survival rates among this high-risk population. Research presented today at the American College of Cardiology's 56th Annual Scientific Session offers new insight into the most effective therapies for patients with severe left ventricular dysfunction, cardiogenic shock and perioperative hypertension. ACC.07 is the premier cardiovascular medical meeting, bringing together specialists from around the world to further breakthroughs in cardiovascular medicine.

F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Guided Management of Patients with Coronary Artery Disease and Severe Left Ventricular Dysfunction: A Randomized Controlled Trial (PARR-2) (Presentation Number: 412-7)

Positron emission tomography (PET) is a widely used research tool to map normal brain and heart function. Recently, it has proven beneficial in assisting physicians in selecting therapies by visualizing a patient's heart metabolism. The PET and Recovery Following Revascularization (PARR-2) study looked at patients with poor left ventricular (LV) function and used PET imaging to guide therapy choices, seeking to determine if using the imaging technique would result in a better outcome than standard therapy.

Study investigators from the University of Ottawa Heart Institute, University of Washington and eight other sites enrolled 430 patients who were referred for revascularization, cardiac transplantation or heart failure, or were likely to benefit from fluorodeoxyglucose (FDG, a commonly used injection agent that is visualized on tomography) PET-guided therapy. A total of 218 patients received PET-guided therapy and 212 patients received the standard therapy. Researchers tracked the composite rates of ca
'"/>

Contact: Leslie Humbel
lhumbel@spectrumscience.com
504-613-2418
American College of Cardiology
26-Mar-2007


Page: 1 2 3 4 5

Related medicine news :

1. Novel therapy combinations gain ground in treating hepatitis
2. Drug combinations improve survival for patients with heart disease
3. Hormone therapy offers new hope for ovarian cancer patients
4. TB test offers patients quicker and easier diagnosis
5. Panel offers guidelines on skin reactions to new class of cancer drugs
6. Supersize me mice research offers grim warning for Americas fast food consumers
7. Developments in tissue engineering offer new sources for stem cell treatments
8. Targeted nanoparticles incorporating siRNA offer promise for cancer treatment
9. New treatment offers relief from chronic back pain
10. Commonly used drug offers promise for premature babies
11. Vitamin D supplements may offer cheap and effective immune system boost against TB

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Drug intervention combinations offer benefit severe CVD

(Date:5/25/2013)... Bradley, Illinois (PRWEB) May 25, 2013 ... assisted living community, is hosting an American Red Cross ... May 30. , The community, which is located at ... of all incomes, including those on Medicaid, who need ... give the Gift of Life," says Andrea Arview Frey, ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 Superior Magnetics ... relieves pain in seconds for arthritis, tendinitis and bursitis ... alternative pain relief products announced a magnetic bracelet ... magnetic bracelet for pain relief is demonstrated at fairs ... uses 5400 Gauss magnets and has customers often report ...
(Date:5/25/2013)... 25, 2013 The product liability ... Imprelis lawsuit on behalf of 23 property owners who ... was filed on April 25, 2013 and names E.I. DuPont ... filed Wright & Schulte Imprelis lawsuits, this case will be ... , This Imprelis lawsuit alleges that, due ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Cheap Concert Tickets ... Taylor Swift fans can add code RED for added savings. ... sales, setting a record 1.2 million sales during the first week. ... at the top of the Billboard Album charts, with sales of ... album sales are expected to continue at a fast clip ...
(Date:5/24/2013)... Compromise is often cited as crucial for relationships, though ... and comfort. However, many couples find themselves facing dilemmas as ... can cause added stress, lost sleep, and some resentment. What’s ... issues in their latest article on the subject. , ... to do When You Disagree on the Best Mattress ”, ...
Breaking Medicine News(10 mins):Health News:Carbondale Affordable Assisted Living Community to Host Red Cross Blood Drive 2Health News:Magnetic bracelet relieves pain in seconds announces Superior Magnetics 2Health News:Imprelis Lawsuit Filed on Behalf of Multiple Property Owners Nationwide Who Allege Imprelis Use Resulted In Extensive Tree Damage and Death, Reports Wright & Schulte 2Health News:Imprelis Lawsuit Filed on Behalf of Multiple Property Owners Nationwide Who Allege Imprelis Use Resulted In Extensive Tree Damage and Death, Reports Wright & Schulte 3Health News:Imprelis Lawsuit Filed on Behalf of Multiple Property Owners Nationwide Who Allege Imprelis Use Resulted In Extensive Tree Damage and Death, Reports Wright & Schulte 4Health News:Taylor Swift Tickets: Cheap Concert Tickets has Slashed Prices on Taylor Swift Concert Tickets in Arlington/Dallas, Philadelphia, East Rutherford, Los Angeles & Tacoma 2Health News:Taylor Swift Tickets: Cheap Concert Tickets has Slashed Prices on Taylor Swift Concert Tickets in Arlington/Dallas, Philadelphia, East Rutherford, Los Angeles & Tacoma 3Health News:What’s The Best Bed Offers Mattress & Sleep Solutions for Opposite Couples 2
(Date:5/24/2013)... , May 24, 2013 Solta Medical, Inc. ... medical aesthetics market, today reported Dr. Edward W. ... Company,s Board of Directors effective immediately.  Dr. Knowlton is the ... had served as a director since 1996. "On ... our management team, I would like to thank Ed for ...
(Date:5/24/2013)... BEIJING , May 24, 2013 China ... "Company"), a leading fully integrated plasma-based biopharmaceutical company in ... Company has recently learned from a public announcement issued ... a public company listed on Shenzhen Stock Exchange, that ... Chan ("Ms. Chan"), one of the shareholders ...
(Date:5/24/2013)... BEIJING , May 24, 2013  Sinovac ... leading provider of biopharmaceutical products in ... main operating subsidiary company of Sinovac, obtained the ... (GMP Certificate) from the China State and Food ... district bulk production plants, and its Changping filing ...
Breaking Medicine Technology:Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3
Cached News: